Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
ATORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000767188 (+8 more)
- LEI:
- 549300E15VI0MB7LXV19
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Sector:
- Manufacturing
Description
Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-30 15:00 |
Change in number of shares and votes in Alligator Bioscience
|
English | 57.0 KB | ||
| 2024-12-20 13:00 |
Alligator Bioscience AB announces outcome of exercise of warrants series TO 9
|
English | 63.6 KB | ||
| 2024-12-20 13:00 |
Alligator Bioscience AB meddelar utfall för nyttjandet av teckningsoptioner ser…
|
Swedish | 64.6 KB | ||
| 2024-12-13 08:00 |
Last day of trading in warrants series TO 9 in Alligator Bioscience AB is 13 De…
|
English | 66.9 KB | ||
| 2024-12-13 08:00 |
Sista dag för handel med teckningsoptioner serie TO 9 i Alligator Bioscience AB…
|
Swedish | 68.3 KB | ||
| 2024-12-04 14:01 |
Alligator Bioscience publishes financial calendar for 2025
|
English | 67.5 KB | ||
| 2024-12-03 12:15 |
Alligator Bioscience beslutar om omvandling av C-aktier till stamaktier för lev…
|
Swedish | 56.4 KB | ||
| 2024-12-02 17:35 |
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 9 i Allig…
|
Swedish | 69.7 KB | ||
| 2024-12-02 17:35 |
Exercise price determined for the exercise of warrants series TO 9 in Alligator…
|
English | 69.4 KB | ||
| 2024-12-02 08:45 |
Notice of extraordinary general meeting in Alligator Bioscience AB
|
English | 101.6 KB | ||
| 2024-12-02 08:45 |
Kallelse till extra bolagsstämma i Alligator Bioscience AB
|
Swedish | 96.4 KB | ||
| 2024-12-02 08:35 |
Alligator Bioscience carries out a rights issue of units of approximately SEK 2…
|
English | 115.0 KB | ||
| 2024-12-02 08:35 |
Alligator skärper fokus på mitazalimab och planerar omstrukturering för att för…
|
Swedish | 68.6 KB | ||
| 2024-11-19 17:30 |
Alligator announces sale of future financial commitments for two bispecific ant…
|
English | 61.3 KB | ||
| 2024-11-19 17:30 |
Alligator säljer rätten till framtida finansiella åtaganden för två bispecifika…
|
Swedish | 62.4 KB |
Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alligator Bioscience
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alligator Bioscience via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-28 | Peter Ostler | Other | Sell | 1,658,134 | 179,045.31 SEK |
| 2024-04-11 | Staffan Encrantz | Other | Sell | 44,108,581 | 47,196,181.67 SEK |
| 2022-10-27 | Sören Bregenholt Frederiksen | Other | Buy | 52,000 | 72,748.00 SEK |
| 2022-10-25 | Marie Svensson | Other | Buy | 12,000 | 16,632.00 SEK |
| 2022-08-19 | Sören Bregenholt Frederiksen | Other | Buy | 13,906 | 25,726.10 SEK |
| 2022-08-18 | Sören Bregenholt Frederiksen | Other | Buy | 31,094 | 56,911.35 SEK |
| 2022-05-31 | Peter Ostler | Other | Buy | 100,000 | 151,500.00 SEK |
| 2022-05-04 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,895.00 SEK |
| 2022-05-02 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 50,811.00 SEK |
| 2022-04-30 | Sören Bregenholt Frederiksen | Other | Buy | 30,000 | 51,171.00 SEK |
Peer Companies
